Di Filippo, Massimiliano
Portaccio, Emilio
Mancini, Andrea
Calabresi, Paolo
Article History
First Online: 29 August 2018
Competing interests
: M.D.F. participated on advisory boards for and received speaker or writing honoraria and funding for travelling from Bayer, Biogen Idec, Genzyme, Merck, Novartis, Roche and Teva. E.P. served on scientific advisory boards for Biogen Idec and Merck Serono, received honoraria for speaking and funding for travelling from Biogen, Genzyme, Novartis, Merck and Teva and received research support from Merck Serono. A.M. declares no competing interests. P.C. participated on advisory boards for and received funding for travelling, speaker honoraria and research support from AbbVie, Biogen Idec, Merck, Genzyme, Novartis, Prexton, Teva, UCB and Zambon.